Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 -- 1101 2022-05-12 14:41:22 |
2 format change Meta information modification 1101 2022-05-13 03:11:33 |

Video Upload Options

We provide professional Video Production Services to translate complex research into visually appealing presentations. Would you like to try it?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Nhlapo, N.; Dzogbewu, T.; , . Nanofiber Polymers for Biomedical Applications. Encyclopedia. Available online: https://encyclopedia.pub/entry/22875 (accessed on 29 November 2024).
Nhlapo N, Dzogbewu T,  . Nanofiber Polymers for Biomedical Applications. Encyclopedia. Available at: https://encyclopedia.pub/entry/22875. Accessed November 29, 2024.
Nhlapo, Nthabiseng, Thywill Dzogbewu,  . "Nanofiber Polymers for Biomedical Applications" Encyclopedia, https://encyclopedia.pub/entry/22875 (accessed November 29, 2024).
Nhlapo, N., Dzogbewu, T., & , . (2022, May 12). Nanofiber Polymers for Biomedical Applications. In Encyclopedia. https://encyclopedia.pub/entry/22875
Nhlapo, Nthabiseng, et al. "Nanofiber Polymers for Biomedical Applications." Encyclopedia. Web. 12 May, 2022.
Nanofiber Polymers for Biomedical Applications
Edit

The features of the nanofibers (NFs) that are used to coat biomedical Ti-based implants are predominantly dependent on the type of polymer employed. Applicable polymers are categorized as either natural or synthetic based on their source and composition. Natural polymers, namely cellulose, collagen, gelatin, chitosan, chitin, dextrose and silk fibroin, have been electrospun into NF scaffolds.

nanofibers polymers titanium implants

1. Introduction

The features of the NFs that are used to coat biomedical Ti-based implants are predominantly dependent on the type of polymer employed [1]. Applicable polymers are categorized as either natural or synthetic based on their source and composition [2][3][4]. Natural polymers, namely cellulose, collagen, gelatin, chitosan, chitin, dextrose and silk fibroin, have been electrospun into NF scaffolds [4][5][6]. Kadavil et al. [7] report on gelatin providing cellular attachment and adhesion of human stem cells, which is typical of most natural polymers. However, natural polymers are limited in their clinical application due to being immunogenic, exhibiting batch-to-batch differences, limited availability, expensive production and vulnerability to cross-contamination [3][7]. Moreover, natural polymers lack mechanical strength and have a relatively rapid degradation rate due to their hydrophilic nature, limiting their use in long-term clinical processes. These limitations of natural polymers may be remedied through the use of synthetic polymers [2][3][7].
Synthetic polymers have numerous advantages in comparison to their natural counterparts, namely cost-effectiveness and durability, and the majority of them have stable mechanical properties for applications in load-bearing tissue engineering scaffolds [2][3][7]. Owed to their ease of processing and biocompatibility, the most popular synthetic polymers include poly(ε-caprolactone) (PCL), poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), poly(glycolic acid) (PGA), poly(ethylene oxide) (PEO) and poly(vinyl alcohol) (PVA) [5][7][8]. These polymers have been approved by the United States Food and Drug Administration (FDA) for use in human medical devices, which emphasizes their in vivo applicability and that their toxicity factor has been evaluated [3][4][9][10][11][12][13].
In addition to biocompatibility, biodegradability and lack of toxicity are common properties among synthetic polymers relevant for coating surfaces of biometals [14][15]. Biodegradation may be defined by hydrolysis in physiological conditions (as in the human body) [14][15]. Boia et al. [12] greatly emphasized the slow degradation of PCL-based implants, which is supported by Perumal et al. [13], who reported that PCL has been said to gradually degrade when compared to PLGA and PLA. The degradation rate is dependent on the hydrophilicity of the monomeric units, and basically, the comparative degradation rates of the polymers may be summarized in terms of length of the degradation period as [3][13][16]: PCL > PLA > PLGA > PGA > hydrophilic polymers (such as PEO and PVA). Table 1 lists the distinguishing properties of synthetic polymers used in the biomedical field.
Table 1. Overview of the characteristics of synthetic polymers.

Polymer

Properties

Applications

Degradation Rate

Ref.

Poly(ε-caprolactone) (PCL)

Hydrophobic aliphatic polyester; slow degradation rate; bioactive; flexible mechanical properties; effectively entraps bactericidal material; semi-crystalline; semi-permeable

Long-term implants; bone graft material; tissue engineering scaffolds; drug-delivery systems

2–4 years

[3][17][18]

Poly(lactic acid) (PLA)

Hydrophobic aliphatic polyester; slow degradation rate; bioactive; tunable mechanical properties; crystalline; porous; stereoisomers: poly(L-lactide)

(PLLA), poly(D-lactide) (PDLA), and poly(DL-lactide) (PDLLA)

Biomedical coating; load-bearing applications; orthopedic fixation devices; tissue engineering; three-dimensional (3D) printed scaffolds; drug-delivery systems

>24 months

[3][17][18]

Poly(lactic-co-glycolic acid) (PLGA)

Hydrophobic/hydrophilic balance; intermediate/adjustable degradation rate; PLA/PGA copolymer; crystalline; semi-permeable; low osteoinductivity

Copolymer for development of bone substitute constructs; bone regeneration; orthopedic implants; tissue engineering

6–12 months

[2][3][7][18]

Poly(glycolic acid) (PGA)

Hydrophilic aliphatic polyester; fast degradation rate; tunable material properties; crystalline; low solubility; semi-permeable

Implants, tissue engineering; drug delivery; biological adhesives; open soft tissue wounds

2–4 weeks

[2][3][18][19]

Poly(ethylene oxide) (PEO)

Hydrophilic; synthetic hydrogel

Composite functional materials; hydrogel coatings; blood contact

-

[1][11][20][21]

Poly(vinyl alcohol) (PVA)

Hydrophilic; fast degradation; gel-forming properties; good film-forming; good chemical resistance; semi-crystalline

Implants; tissue engineering

-

[7][9][11][22]

2. Hybridization of Polymers

Despite the various clinical advantages of synthetic polymers, their disadvantages—for instance, lack of cell-specific recognition sites due to their smooth and hydrophobic surfaces—reduce their applications in implantable devices [4]. In addition, water-soluble synthetic polymers, such as PVA, exhibit poor mechanical properties [7]. Studies indicate that one of the most effective strategies applied to subdue the limitations of polymer groups is the production of novel composite fibers through the combination of various polymers [1][6][7][23]. The results of Jahanmard et al. [24] indicated that the biological properties of bi-layered PCL/PLGA composite NFs far exceeded those of the single layers. Synthetic polymers are often fused with natural polymers to form fibers with optimized mechanical properties, degradation rates and bioactivity while maintaining the similarity to the ECM and promoting cell attachment [4][7]. Examples of single and hybrid electrospun NFs are illustrated by the scanning electron microscope (SEM) images in Figure 1.
Figure 1. Scanning electron microscope (SEM) micrograph illustrations of nanofibers (NFs) composed of (a) pure synthetic polymers (i) PCL [6], (ii) PLLA [25] and (iii) PLGA [24]; and (b) synthetic and natural polymer composites of (i) PCL/Collagen [26], (ii) PLLA/Chitosan [25] and (iii) PEO/Chitosan [1].

3. Electrospinning Technique

Electrospinning is a common nanotechnique used to fabricate scaffolds of aligned polymeric NFs with diameters varying between 3 nm and greater than 5 µm [19][27]. The engineered 3D porous scaffolds serve as a pattern to provide mechanical and biochemical support to the surrounding cells relative to the tissue type [28][29]. A simple electrospinning setup (Figure 2) consists of a high voltage power supply (typically between 5 to 30 kV), a piece of feeding equipment (usually a syringe), a spinneret and a collector [5][22][30]. The collector for electrospun fibers is usually on a grounded plate and is usually a metallic material; hence, coating a Ti implant using the electrospinning method is relatively straightforward [27][31][32]. Important factors that govern the quality NFs produced using the electrospinning process include solution parameters (such as polymer structure and viscosity), processing parameters (such as flow, voltage and distance) and ambient conditions [4][26]. By altering these parameters, multiple experimental arrangements of the process, including coaxial, solution and melt electrospinning, are achievable [6][24][33]. Deviations from the basic electrospinning process are necessary to modify the primary properties of NFs and realize a tunable coating towards desired structural and functional properties [6][7][24]. The flexibility of the electrospinning technique is convenient for application in Ti implants intended for the complex human body environment. Several researchers have successfully applied electrospinning to coat Ti [8][28][31][34] and Ti–6Al–4V [1][31][35][36] samples intended for use as human implants. Kadavil et al. [7] notes also that polymers such as PCL and PVA have gained popularity as readily electrospinnable polymers and have been used as a template for the preparation of non-electrospinnable polymers. A specific amount of PEO was used as a fiber-forming additive by Nitti et al. [37] to improve the electrospinnability of chitosan. Therefore, technique modifications allow for the accommodation of the various biopolymer solutions.
Figure 2. Schematic representation of a basic electrospinning horizontal set-up.

References

  1. Boschetto, F.; Doan, H.N.; Vo, P.P.; Zanocco, M.; Zhu, W.; Sakai, W.; Adachi, T.; Ohgitani, E.; Tsutsumi, N.; Mazda, O.; et al. Antibacterial and osteoconductive effects of chitosan/polyethylene oxide (PEO)/bioactive glass nanofibers for orthopedic applications. Appl. Sci. 2020, 10, 2360.
  2. Gentile, P.; Chiono, V.; Carmagnola, I.; Hatton, P.V. An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering. Int. J. Mol. Sci. 2014, 15, 3640–3659.
  3. Song, R.; Murphy, M.; Li, C.; Ting, K.; Soo, C.; Zheng, Z. Current development of biodegradable polymeric materials for biomedical applications. Drug Des. Dev. Ther. 2018, 12, 3117–3145.
  4. Reddy, M.S.; Ponnamma, D.; Choudhary, R.; Sadasivuni, K.K. A comparative re-view of natural and synthetic biopolymer composite scaffolds. Polymers 2021, 13, 1105.
  5. Weng, L.; Xie, J. Smart electrospun nanofibers for controlled drug release: Recent advances and new perspectives. Curr. Pharm. Des. 2015, 21, 1944–1959.
  6. Nemati, S.; Kim, S.-J.; Shin, Y.M.; Shin, H. Current progress in application of polymeric nanofibers to tissue engineering. Nano Converg. 2019, 6, 36.
  7. Kadavil, H.; Zagho, M.; Elzatahry, A.; Altahtamouni, T. Sputtering of electrospun polymer-based nanofibers for biomedical applications: A perspective. Nanomaterials 2019, 9, 77.
  8. Şimşek, M.; Aldemir, S.D.; Gümüşderelioğlu, M. Anticellular PEO coatings on titanium surfaces by sequential electrospinning and crosslinking processes. Emergent Mater. 2019, 2, 169–179.
  9. Chong, S.-F.; Smith, A.A.A.; Zelikin, A.N. Microstructured, functional PVA hydrogels through bioconjugation with oligopeptides under physiological conditions. Small 2013, 9, 942–950.
  10. Marin, E.; Briceño, M.I.; Caballero-George, C. Critical evaluation of biodegradable polymers used in nanodrugs. Int. J. Nanomed. 2013, 8, 3071–3091.
  11. Montoro, S.R.; Medeiros, S.d.F.; Alves, G.M. Nanostructured hydrogel. In Nanostructured Polymer Blends; Thomas, S., Shanks, R., Chandrasekharakurup, S., Eds.; Elsevier Inc.: Oxford, UK, 2014; pp. 325–355.
  12. Boia, R.; Dias, P.A.N.; Martins, J.M.; Galindo-Romero, C.; Aires, I.D.; Vidal-Sanz, M.; Agudo-Barriuso, M.; de Sousa, H.C.; Ambrósio, A.F.; Bragad, M.E.M.; et al. Po-rous poly(ε-caprolactone) implants: A novel strategy for efficient intraocular drug delivery. J. Control Release 2019, 316, 331–348.
  13. Perumal, G.; Sivakumar, P.M.; Nandkumar, A.M.; Doble, M. Synthesis of magnesium phosphate nanoflakes and its PCL composite electrospun nanofiber scaffolds for bone tissue regeneration. Mater. Sci. Eng. C 2020, 109, 110527.
  14. Chen, P. A Preliminary Discourse on Adhesion of Nanofibers Derived from Electrospun Polymers. Ph.D. Thesis, University of Akron, Akron, OH, USA, 2013.
  15. Maitz, M.F. Applications of synthetic polymers in clinical medicine. Biosurf. Biotribol. 2015, 1, 161–176.
  16. Jeong, S.I.; Kim, B.-S.; Kang, S.W.; Kwon, J.H.; Lee, Y.M.; Kim, S.H.; Kim, Y.H. In vivo biocompatibilty and degradation behavior of elastic poly(L-lactide-co-epsilon-caprolactone) scaffolds. Biomaterials 2004, 25, 5939–5946.
  17. Nathanael, A.J.; Oh, T.H. Biopolymer coatings for biomedical applications. Polymers 2020, 12, 3061.
  18. Ravichandran, R. Biomimetic Surface Modification of Dental Implant for Enhanced Osseointegration. Master’s Thesis, National University of Singapore, Singapore, 2009.
  19. Tian, F.; Hosseinkhani, H.; Hosseinkhani, M.; Khademhosseini, A.; Yokoyama, Y.; Estrada, G.G.; Kobayashi, H. Quantitative analysis of cell adhesion on aligned micro- and nanofibers. J. Biomed. Mater. Res. A 2008, 84, 291–299.
  20. Wang, Y.; Li, M.; Rong, J.; Nie, G.; Qiao, J.; Wang, H.; Wu, D.; Su, Z.; Niu, Z.; Huang, Y. Enhanced orientation of PEO polymer chains induced by nanoclays in electrospun PEO/clay composite nanofibers. Colloid Polym. Sci. 2013, 291, 1541–1546.
  21. Helmus, M.N.; Gibbons, D.F.; Cebon, D. Biocompatibility: Meeting a key functional requirement of next-generation medical devices. Toxicol. Pathol. 2008, 36, 70–80.
  22. Tao, J. Effects of Molecular Weight and Solution Concentration on Electrospinning of PVA. Master’s Thesis, Worcester Polytechnic Institute, Worcester, MA, USA, 2003.
  23. Al Aboody, M.S. Electrospun fabrication and direct coating of bio-degradable fibrous composite on orthopedic titanium implant: Synthesis and characterizations. Mater. Res. Express 2021, 8, 015307.
  24. Jahanmard, F.; Croes, M.; Castilho, M.; Majed, A.; Steenbergen, M.J.; Lietaert, K.; Vogely, H.C.; van der Wal, B.C.H.; Stapel, D.A.C.; Malda, J.; et al. Bactericidal coating to prevent early and delayed implant-related infections. J. Control. Release 2020, 326, 38–52.
  25. Chen, S.; Hao, Y.; Cui, W.; Chang, J.; Zhou, Y. Biodegradable electrospun PLLA/chitosan membrane as guided tissue regeneration membrane for treating periodontitis. J. Mater. Sci. 2013, 48, 6567–6577.
  26. Miele, D.; Catenacci, L.; Rossi, S.; Sandri, G.; Sorrenti, M.; Terzi, A.; Giannini, C. Collagen/PCL nanofibers electrospun in green solvent by DOE assisted process. An in-sight into collagen contribution. Materials 2020, 13, 4698.
  27. Pham, Q.N.; Sharma, U.; Mikos, A.G. Electrospinning of polymeric nanofibers for tissue engineering applications: A review. Tissue Eng. 2006, 12, 1197–1211.
  28. Kiran, A.S.K.; Kumar, T.S.S.; Sanghavi, R.; Doble, M.; Ramakrishna, S. Antibacterial and bioactive surface modifications of titanium implants by PCL/TiO2 nanocompo-site coatings. Nanomaterials 2018, 8, 860.
  29. Jun, I.; Han, H.-S.; Edwards, J.R.; Jeon, H. Electrospun fibrous scaffolds for tissue engineering: Viewpoints on architecture and fabrication. Int. J. Mol. Sci. 2018, 19, 745.
  30. Zhao, Y.; Qiu, Y.; Wang, H.; Chen, Y.; Jin, S.; Chen, S. Preparation of nanofibers with renewable polymers and their application in wound dressing. Int. J. Polym. Sci. 2016, 2016, 1–17.
  31. Ravichandran, R.; Ng, C.C.H.; Liao, S.; Pliszka, D.; Raghunath, M.; Ramakrishna, S.; Chan, C.K. Biomimetic surface modification of titanium surfaces for early cell capture by advanced electrospinning. Biomed. Mater. 2012, 7, 015001.
  32. Teo, W.-E. Electrospun Coated Metal Implants. Available online: http://electrospintech.com/coatedmetal.html (accessed on 14 January 2022).
  33. Lee, B.-Y.; Behler, K.; Kurtoglu, M.E.; Wynosky-Dolfi, M.A.; Rest, R.F.; Gogotsi, Y. Titanium dioxide-coated nanofibers for advanced filters. J. Nanoparticle Res. 2010, 12, 2511–2519.
  34. Abdal-hay, A.; Hwang, M.-G.; Lim, J.K. In vitro bioactivity of titanium implants coated with bicomponent hybrid biodegradable polymers. J. Sol-Gel Sci. Technol. 2012, 64, 756–764.
  35. Khandaker, M.; Riahinezhad, S.; Sultana, F.; Morris, T.; Wolf, R.; Vaughan, M. Effect of collagen-polycaprolactone nanofibers matrix coating on the In vitro cytocompatibility and in vivo bone responses of titanium. J. Med. Biol. Eng. 2018, 38, 197–210.
  36. Khandaker, M.; Riahinezhad, S.; Williams, W.R.; Wolf, R. Microgroove and collagen-poly(ε-caprolactone) nanofiber mesh coating improves the mechanical stability and osseointegration of titanium implants. Nanomaterials 2017, 7, 145.
  37. Nitti, P.; Gallo, N.; Natta, L.; Scalera, F.; Palazzo, B.; Sannino, A.; Gervaso, F. Influence of nanofiber orientation on morphological and mechanical properties of electrospun chitosan mats. J. Healthc. Eng. 2018, 2018, 3651480.
More
Information
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : , ,
View Times: 952
Revisions: 2 times (View History)
Update Date: 13 May 2022
1000/1000
ScholarVision Creations